Sirtex Medical enters agreement for $1.58 billion takeover from Varian Medical

Company News

by Kathy Skantzos

Medical device company Sirtex Medical (ASX:SRX) has announced it has entered into an agreement with US medical giant Varian Medical Systems which has offered to takeover the company for $1.58 billion.

Varian Medical Systems is offering $28.00 a share in the cash takeover, a 49 per cent premium to the $18.83 price that Sirtex shares last traded at before a trading halt on Monday 29 January 2018.

The board needs approval from shareholders and says it recommends shareholders vote in favour of the takeover at a meeting to be held in May 2018.

Sirtex revealed it received a number of acquisition proposals late last year.

The Californian-based New York Stock Exchange-listed medical company is a developer of cancer products and has a market capitalisation of US$11.8 billion.

Shares in Sirtex Medical (ASX:SRX) last traded at $18.83 on Monday.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.